Clinical Trial

Using Near-Infrared Light to Better Understand Peripheral Artery Disease

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to better understand how blood flows and how oxygen is utilized in the lower limbs of people who suffer from peripheral artery disease. This study will also assess how these factors affect treatment outcomes. Specific aims include: Aim 1: Utilize BB-NIR-DCS to differentiate PAD patients experiencing primary oxygen delivery limitations from those suffering from mitochondrial dysfunction. Aim 2: Test the efficacy of BB-NIR-DCS at predicting individual responses to vascular intervention.
Trial Details
NCT Number NCT07313410
Lead Sponsor The University of Texas at Arlington
Conditions Peripheral Artery Disease (PAD)
Enrollment 120 participants
Start Date 2025-11-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-02